| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 638 | 4.875 | 6.028 | 13.882 | 14.755 | 16.868 | 27.228 | 15.787 | 16.848 |
| Total Income - EUR | - | 640 | 7.173 | 6.028 | 13.882 | 14.841 | 16.868 | 28.428 | 16.531 | 16.848 |
| Total Expenses - EUR | - | 1.762 | 7.155 | 7.678 | 8.624 | 10.071 | 16.167 | 9.347 | 14.259 | 13.307 |
| Gross Profit/Loss - EUR | - | -1.121 | 18 | -1.650 | 5.258 | 4.770 | 701 | 19.081 | 2.272 | 3.541 |
| Net Profit/Loss - EUR | - | -1.141 | -197 | -1.831 | 4.842 | 4.359 | 364 | 18.405 | 2.137 | 3.114 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nortonmed Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 694 | 325 | 0 | 0 | 0 |
| Current Assets | - | 125 | 2.298 | 1.854 | 8.378 | 13.229 | 18.569 | 32.346 | 26.799 | 30.293 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 941 | 0 | 0 |
| Receivables | - | 0 | 0 | 40 | 346 | 999 | 842 | 16.829 | 2.788 | 5.187 |
| Cash | - | 125 | 2.298 | 1.815 | 8.032 | 12.231 | 17.727 | 14.576 | 24.012 | 25.106 |
| Shareholders Funds | - | -1.096 | -1.275 | -3.082 | 1.819 | 6.144 | 6.372 | 18.453 | 6.190 | 9.269 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.221 | 3.603 | 4.936 | 6.686 | 7.905 | 12.722 | 13.147 | 20.897 | 21.256 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 746 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nortonmed Srl-D